Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (GDRX) operates a leading digital healthcare platform that transforms prescription affordability through price transparency tools and pharmacy benefit solutions. This news hub provides investors and industry professionals with essential updates on financial performance, strategic initiatives, and regulatory developments impacting the company’s role in reshaping medication access.
Discover official press releases covering quarterly earnings, partnership announcements with healthcare stakeholders, and expansions of the company’s prescription savings ecosystem. Our curated collection includes analyses of market trends affecting GoodRx’s position in digital health, updates on telehealth integrations, and coverage of consumer affordability programs.
Key updates include developments in PBM collaborations, Medicare/Medicaid pricing initiatives, and technological advancements within the GoodRx platform. Bookmark this page to monitor how the company navigates evolving healthcare regulations while maintaining its mission to reduce out-of-pocket medication costs for millions of Americans.
GoodRx Holdings Inc. (NASDAQ: GDRX) announced its participation in key investor conferences in March. Executives will present at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL, on March 8 at 7:25 a.m. PT; at the Cowen 42nd Annual Health Care Conference virtually on March 9 at 8:10 a.m. PT; and at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference in Palm Beach, FL, on March 15 at 6:35 a.m. PT. Live webcasts and archived recordings will be accessible via their Investor Relations website.
GoodRx Holdings Inc. (NASDAQ: GDRX) will release its fourth quarter and full year 2021 financial results after U.S. markets close on February 28, 2022. A conference call will occur at 2:00 p.m. PT to discuss the results and future outlook. The financial results will be available on their investor relations website. GoodRx, a leading digital healthcare platform, has helped consumers save over $35 billion since 2011, establishing itself as a crucial resource for affordable healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live webcast of the presentation will be accessible via the Company’s Investor Relations website, and an archived recording will be available for at least 30 days post-conference. Since its inception in 2011, GoodRx has helped Americans save over $35 billion, making healthcare more affordable and convenient.
GoodRx Holdings Inc. (NASDAQ: GDRX) has announced participation in two upcoming investor conferences. The first is the Credit Suisse 25th Annual Technology Conference on December 1, 2021, at 1:20 p.m. PT in Scottsdale, AZ. The second is the Barclays Global Technology, Media and Telecommunications Conference on December 7, 2021, at 11:25 a.m. PT, held virtually. Live webcasts and presentation materials will be accessible on the Company's Investor Relations website, with archived recordings available for 30 days post-conference.
GoodRx has released its State of Telehealth report, highlighting significant changes in telehealth usage due to the COVID-19 pandemic. Over 1,600 providers and patients were surveyed, revealing that 40% of consumers feel they interact more with providers via telehealth. Additionally, 70% of providers noted improved continuity of care. Post-pandemic, 60% of consumers plan to adopt a hybrid model of care. While 45% of providers reported higher no-show rates for telehealth appointments, overall satisfaction remains high, with GoodRx's telehealth service achieving a 92% satisfaction rate and saving consumers an estimated $243 million in medical costs.
GoodRx Holdings, Inc. (GDRX) announced its third quarter 2021 financial results, highlighting its role as a digital healthcare resource that has saved consumers $35 billion since inception in 2011. The company hosted a conference call on November 10, 2021, at 2:00 PM PT to discuss these results and its business outlook. GoodRx is recognized as one of the most downloaded medical apps, emphasizing its significant impact on healthcare affordability and access in the U.S.
GoodRx Holdings Inc. (NASDAQ: GDRX) will release its third quarter 2021 financial results on November 10, 2021, after U.S. market close. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET), discussing the results and future business outlook. A press release with a link to a shareholder letter will be available on their investor relations website prior to the call. GoodRx, since its inception in 2011, has saved consumers over $30 billion in healthcare costs and remains a leading medical app in the U.S.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Morgan Stanley Annual Spark Conference on Thursday, October 14, at 1:15 p.m. PT in Beverly Hills, CA. The presentation can be streamed live via the Company's Investor Relations website, with an archived version available for at least 30 days afterward. GoodRx is a digital healthcare resource that has saved consumers over $30 billion since 2011, aiming to make healthcare affordable and accessible for all Americans.
GoodRx has partnered with Fetch Rewards, enabling its 10 million active users to earn rewards points when using GoodRx coupons for medications. This collaboration allows users to access significant medication discounts at over 70,000 pharmacies nationwide, with potential savings of up to 80%. Fetch users can seamlessly integrate these savings and receive rewards that may be redeemed for gift cards or donations. The partnership aims to support millions who struggle with medication affordability and enhance user engagement through Fetch's loyalty program.
GoodRx (GDRX) has launched GoodRx Health, a platform providing research-based answers to health questions. This initiative aims to deliver concise, actionable knowledge through various tools including GoodRx Answers and award-winning videos. The platform is backed by an editorial team of doctors and pharmacists, focusing on areas like health knowledge, financial guidance, and trustworthy research. With nearly 20 million monthly users, GoodRx seeks to enhance consumer advocacy in healthcare decisions and capture a larger share of the $30 billion addressable market.